Floatz logo

Phentermine

Phentermine Withdrawal

Center for Weight Management, CaliforniaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Phentermine Withdrawal cohort.

Asset / SponsorPhaseRating
Probenecid
University of Calgary
Phase 2CCC
Lofexidine
USWM, LLC (dba US WorldMeds)
Phase 2CCC
Buprenorphine
Medical University of South Carolina
Phase 1/2CCC
Buspirone
Johns Hopkins University
Phase 1CC
CBOT
Evon Medics LLC
Phase 2NR

Same molecule, other indications

Phentermine is also rated in:

obesity disorderDormant
BBB
Indicative ·
73 / 100
View asset →
obesity disorderDormant
BB
Indicative ·
69 / 100
View asset →
essential hypertensionDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →